A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
August 31, 2013
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Conditions
Healthy Adult Subjects
Interventions
DRUG
Metadoxine (MG01CI )
Trial Locations (1)
Unknown
Clinical research center Souraski medical center, Tel Aviv
All Listed Sponsors
lead
Alcobra Ltd.
INDUSTRY
NCT01933997 - A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers | Biotech Hunter | Biotech Hunter